Current Updates and Unmet Needs of Brain MRI-Based Artificial Intelligence Software for Patients With Neurodegenerative Diseases in the Republic of Korea

키워드

참고문헌 (62)

1. Jack CR Jr, "Alzheimer disease : new concepts on its neurobiology and the clinical role imaging will play", Radiology, 263, pp.344~361 (2012)
2. Jack CR Jr, "NIA-AA research framework : toward a biological definition of Alzheimer’s disease", Alzheimers Dement, 14, pp.535~562 (2018)
3. 박미나, "Structural MR Imaging in the Diagnosis of Alzheimer’s Disease and Other Neurodegenerative Dementia: Current Imaging Approach and Future Perspectives", Korean Journal of Radiology, 17(6), pp.827~845 (2016), 대한영상의학회[DOI]
4. Lee Ji Young, "Clinically Available Software for Automatic Brain Volumetry: Comparisons of Volume Measurements and Validation of Intermethod Reliability", Korean Journal of Radiology, 22(3), pp.405~414 (2021), 대한영상의학회[DOI]
5. Brewer JB, "Fully-automated quantification of regional brain volumes for improved detection of focal atrophy in Alzheimer disease", AJNR Am J Neuroradiol, 30, pp.578~580 (2009)
6. Tanpitukpongse TP, "Predictive utility of marketed volumetric software tools in subjects at risk for Alzheimer disease : do regions outside the hippocampus matter?", AJNR Am J Neuroradiol, 38, pp.546~552 (2017)
7. Wang C, "Automated brain volumetrics in multiple sclerosis : a step closer to clinical application", J Neurol Neurosurg Psychiatry, 87, pp.754~757 (2016)
8. Scheltens P, "Atrophy of medial temporal lobes on MRI in"probable"Alzheimer’s disease and normal ageing : diagnostic value and neuropsychological correlates", J Neurol Neurosurg Psychiatry, 55, pp.967~972 (1992)
9. Cavallin L, "Overtime reliability of medial temporal lobe atrophy rating in a clinical setting", Acta Radiol, 53, pp.318~323 (2012)
10. Park HY, "Diagnostic performance of the medial temporal lobe atrophy scale in patients with Alzheimer’s disease : a systematic review and meta-analysis", Eur Radiol, 31, pp.9060~9072 (2021)
11. Park HY, "Diagnostic performance of hippocampal volumetry in Alzheimer’s disease or mild cognitive impairment : a meta-analysis", Eur Radiol, 32, pp.6979~6991 (2022)
12. Persson K, "Finding of increased caudate nucleus in patients with Alzheimer’s disease", Acta Neurol Scand, 137, pp.224~232 (2018)
13. Ochs AL, "Comparison of automated brain volume measures obtained with NeuroQuant®and FreeSurfer", J Neuroimaging, 25, pp.721~727 (2015)
14. Suh CH, "Development and validation of a deep learning–based automatic brain segmentation and classification algorithm for Alzheimer disease using 3D T1-weighted volumetric images", AJNR Am J Neuroradiol, 41, pp.2227~2234 (2020)
15. Kim JS, "Deep learning-based diagnosis of Alzheimer’s disease using brain magnetic resonance images : an empirical study", Sci Rep, 12, pp.18007~ (2022)
16. Kim REY, "Deep learning-based segmentation to establish East Asian normative volumes using multisite structural MRI", Diagnostics(Basel), 11, pp.13~ (2020)
17. Bae JB, "Identification of Alzheimer’s disease using a convolutional neural network model based on T1-weighted magnetic resonance imaging", Sci Rep, 10, pp.22252~ (2020)
18. Song M, "Diagnostic classification and biomarker identification of Alzheimer’s disease with random forest algorithm", Brain Sci, 11, pp.453~ (2021)
19. You Joung Kim, "Prevalence and Trends of Dementia in Korea: A Systematic Review and Meta-Analysis", Journal of Korean Medical Science, 29(7), pp.903~912 (2014), 대한의학회
20. Erkinjuntti T, "Clinical criteria for vascular dementia : the NINDSAIREN criteria", Dementia, 5, pp.189~192 (1994)
21. Fazekas F, "Pathologic correlates of incidental MRI white matter signal hyperintensities", Neurology, 43, pp.1683~1689 (1993)
22. Noh Y, "A new classification system for ischemia using a combination of deep and periventricular white matter hyperintensities", J Stroke Cerebrovasc Dis, 23, pp.636~642 (2014)
23. Brune S, "Lesionquant for assessment of MRI in multiple sclerosis—a promising supplement to the visual scan inspection", Front Neurol, 11, pp.546744~ (2020)
24. Joo L, "Diagnostic performance of deep learning-based automatic white matter hyperintensity segmentation for classification of the Fazekas scale and differentiation of subcortical vascular dementia", PLoS One, 17, pp.e0274562~ (2022)
25. Björklund A, "Dopamine neuron systems in the brain : an update", Trends Neurosci, 30, pp.194~202 (2007)
26. Fearnley JM, "Ageing and Parkinson’s disease: substantia nigra regional selectivity", Brain, 114(Pt 5), pp.2283~2301 (1991)
27. Kwon DH, "Seven-tesla magnetic resonance images of the substantia nigra in Parkinson disease", Ann Neurol, 71, pp.267~277 (2012)
28. Mitchell T, "Emerging neuroimaging biomarkers across disease stage in Parkinson disease : a review", JAMA Neurol, 78, pp.1262~1272 (2021)
29. Pyatigorskaya N, "Comparative study of MRI biomarkers in the substantia nigra to discriminate idiopathic Parkinson disease", AJNR Am J Neuroradiol, 39, pp.1460~1467 (2018)
30. Frosini D, "Neuroimaging in Parkinson’s disease : focus on substantia nigra and nigro-striatal projection", Curr Opin Neurol, 30, pp.416~426 (2017)
31. Kim EY, "Nigrosome 1 imaging : technical considerations and clinical applications", Br J Radiol, 92, pp.20180842~ (2019)
32. Kim PH, "Diagnostic performance of loss of nigral hyperintensity on susceptibilityweighted imaging in parkinsonism : an updated meta-analysis", Eur Radiol, 31, pp.6342~6352 (2021)
33. Nam Y, "Imaging of nigrosome 1in substantia nigra at 3T using multiecho susceptibility mapweighted imaging(SMWI)", J Magn Reson Imaging, 46, pp.528~536 (2017)
34. Shin DH, "Automated assessment of the substantia nigra on susceptibility map-weighted imaging using deep convolutional neural networks for diagnosis of Idiopathic Parkinson’s disease", Parkinsonism Relat Disord, 85, pp.84~90 (2021)
35. Hughes AJ, "The accuracy of diagnosis of Parkinsonian syndromes in a specialist movement disorder service", Brain, 125(Pt 4), pp.861~870 (2002)
36. Höglinger GU, "Clinical diagnosis of progressive supranuclear palsy : the movement disorder society criteria", Mov Disord, 32, pp.853~864 (2017)
37. Gilman S, "Second consensus statement on the diagnosis of multiple system atrophy", Neurology, 71, pp.670~676 (2008)
38. Quattrone A, "MR imaging index for differentiation of progressive supranuclear palsy from Parkinson disease and the Parkinson variant of multiple system atrophy", Radiology, 246, pp.214~221 (2008)
39. Kim S, "Diagnostic performance of the magnetic resonance parkinsonism index in differentiating progressive supranuclear palsy from Parkinson’s disease: an updated systematic review and meta-analysis", Diagnostics(Basel), 12, pp.12~ (2021)
40. Chougar L, "Automated categorization of Parkinsonian syndromes using magnetic resonance imaging in a clinical setting", Mov Disord, 36, pp.460~470 (2021)
41. Andersson J, "Idiopathic normal pressure hydrocephalus: epidemiology and diagnostics", pp.2021
42. Williams MA, "Diagnosis and treatment of idiopathic normal pressure hydrocephalus", Continuum(Minneap Minn), 22, pp.579~599 (2016)
43. Mori E, "Guidelines for management of idiopathic normal pressure hydrocephalus: second edition", Neurol Med Chir (Tokyo), 52, pp.775~809 (2012)
44. Relkin N, "Diagnosing idiopathic normal-pressure hydrocephalus", Neurosurgery, 57(3 Suppl), pp.S4~ (2005)
45. Park HY, "Diagnostic performance and interobserver agreement of the callosal angle and Evans' index in idiopathic normal pressure hydrocephalus : a systematic review and meta-analysis", Eur Radiol, 31, pp.5300~5311 (2021)
46. Park HY, "Prognostic utility of disproportionately enlarged subarachnoid space hydrocephalus in idiopathic normal pressure hydrocephalus treated with ventriculoperitoneal shunt surgery : a systematic review and meta-analysis", AJNR Am J Neuroradiol, 42, pp.1429~1436 (2021)
47. Takagi K, "Reliability and interobserver variability of Evans' index and disproportionately enlarged subarachnoid space hydrocephalus as diagnostic criteria for idiopathic normal pressure hydrocephalus", Asian J Neurosurg, 15, pp.107~112 (2020)
48. Duan W, "Evaluation of an artificial intelligent hydrocephalus diagnosis model based on transfer learning", Medicine(Baltimore), 99, pp.e21229~ (2020)
49. Gunter NB, "Automated detection of imaging features of disproportionately enlarged subarachnoid space hydrocephalus using machine learning methods", Neuroimage Clin, 21, pp.101605~ (2019)
50. Greenberg SM, "Cerebral microbleeds : a guide to detection and interpretation", Lancet Neurol, 8, pp.165~174 (2009)
51. Yates PA, "Cerebral microbleeds: a review of clinical, genetic, and neuroimaging associations", Front Neurol, 4, pp.205~ (2014)
52. Poels MM, "Cerebral microbleeds are associated with worse cognitive function : the Rotterdam scan study", Neurology, 78, pp.326~333 (2012)
53. Poels MM, "Prevalence and risk factors of cerebral microbleeds: an update of the Rotterdam scan study", Stroke, 41(10 Suppl), pp.S103~S106 (2010)
54. Jeong SY, "Incidence of amyloid-related imaging abnormalities in patients with Alzheimer disease treated with anti-β-amyloid immunotherapy : a meta-analysis", Neurology, 99, pp.e2092~e2101 (2022)
55. Fan P, "Cerebral microbleed automatic detection system based on the"deep learning"", Front Med(Lausanne), 9, pp.807443~ (2022)
56. Serot JM, "Morphological alterations of the choroid plexus in late-onset Alzheimer’s disease", Acta Neuropathol, 99, pp.105~108 (2000)
57. Wen GY, "Biondi ring tangles in the choroid plexus of Alzheimer’s disease and normal aging brains : a quantitative study", Brain Res, 832, pp.40~46 (1999)
58. Choi JD, "Choroid plexus volume and permeability at brain MRI within the Alzheimer disease clinical spectrum", Radiology, 304, pp.635~645 (2022)
59. Lee Ji Young, "뇌 자기공명영상 뇌용적 분석 소프트웨어의 임상적 적용에 대한 전문가 의견과 권고안", 대한영상의학회지, 82(5), pp.1124~1139 (2021), 대한영상의학회[DOI]
60. 김동욱, "Design Characteristics of Studies Reporting the Performance of Artificial Intelligence Algorithms for Diagnostic Analysis of Medical Images: Results from Recently Published Papers", Korean Journal of Radiology, 20(3), pp.405~410 (2019), 대한영상의학회[DOI]
61. Park SH, "Methodologic guide for evaluating clinical performance and effect of artificial intelligence technology for medical diagnosis and prediction", Radiology, 286, pp.800~809 (2018)
62. 이정빈, "Evaluation of Reproducibility of Brain Volumetry between Commercial Software, Inbrain and Established Research Purpose Method, FreeSurfer", Journal of Clinical Neurology, 17(2), pp.307~316 (2021), 대한신경과학회

관련 논문AI추천